Recombinant Xenopus tropicalis Estradiol 17-beta-dehydrogenase 12 (hsd17b12)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Xenopus tropicalis Estradiol 17-beta-dehydrogenase 12 (hsd17b12)

Recombinant Xenopus tropicalis Estradiol 17-beta-dehydrogenase 12 (hsd17b12) refers to a genetically engineered version of the enzyme hydroxysteroid 17-beta dehydrogenase 12 (HSD17B12) derived from the African clawed frog, Xenopus tropicalis. This enzyme is part of a family of 17-beta hydroxysteroid dehydrogenases, which play crucial roles in steroid hormone metabolism and lipid biosynthesis. While specific research on the recombinant Xenopus tropicalis version of this enzyme is limited, understanding its function and implications can be inferred from studies on its mammalian counterparts.

Function and Role of HSD17B12

HSD17B12 is known for its involvement in the elongation of very long chain fatty acids (VLCFAs), which are essential components of cellular lipids . In mammals, HSD17B12 deficiency leads to severe metabolic disturbances, including systemic inflammation and alterations in lipid profiles . Additionally, HSD17B12 has been implicated in the replication of certain viruses by affecting lipid droplet formation, which is crucial for viral assembly .

Metabolic Implications

Metabolic ProcessEffect of HSD17B12 Deficiency
Lipid HomeostasisDisrupted, leading to systemic inflammation and lipolysis
Fatty Acid ElongationImpaired, affecting VLCFA synthesis
Viral ReplicationReduced due to altered lipid droplet formation

References

  1. Hydroxysteroid (17β) dehydrogenase 12 is essential for metabolic homeostasis:

  2. Characterization of type 12 17beta-hydroxysteroid dehydrogenase:

  3. Lead Optimization of 3,5-Disubstituted-7-Azaindoles:

  4. Very-long-chain fatty acid metabolic capacity of 17-beta hydroxysteroid dehydrogenase 12:

  5. Characterization of Type 12 17β-Hydroxysteroid Dehydrogenase:

  6. Dataset on preliminary phytochemical analysis and antioxidant activity:

  7. HSD17B12 hydroxysteroid 17-beta dehydrogenase 12:

  8. 17β-Hydroxysteroid Dehydrogenase Type 12 in Human Breast:

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our default glycerol concentration is 50% and can serve as a reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its development.
Synonyms
hsd17b12; TNeu053h21.1; Very-long-chain 3-oxoacyl-CoA reductase; 17-beta-hydroxysteroid dehydrogenase 12; 17-beta-HSD 12; 3-ketoacyl-CoA reductase; KAR; Estradiol 17-beta-dehydrogenase 12
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-320
Protein Length
full length protein
Species
Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)
Target Names
hsd17b12
Target Protein Sequence
MATESLAEVPVPGCNCFWYLGVVAAVWWGLRAAWCLLDGARVWVLGSGAQVGPRIGKWAV VTGATDGIGKAYAEELAKRGMNIVLISRSPEKLEEVAKQIKEKFKVETKIIAADFGKPTE IYGRIESGLRDLEIGVLVNNVGVSYEHPEYFLEIPDLENTLDKMININITSVCQMTRLVL PGMLGRGRGVILNISSASGMYPVPLLTVYSATKAFVDFFSRGLQAEYRSKGVTVQSVLPF YVATKLAKIRKPTWDKPSPETYVQSALNTVGLQTQTNGYLPHAIMGWISTSLVPVSTAIS LGMKMNKGLRARFLKRAKQK
Uniprot No.

Target Background

Function

This recombinant Xenopus tropicalis Estradiol 17-beta-dehydrogenase 12 (HSD17B12) catalyzes the second step in the four-reaction long-chain fatty acid elongation cycle. This endoplasmic reticulum-bound enzyme adds two carbons to long- and very long-chain fatty acids (VLCFAs) per cycle. Its 3-ketoacyl-CoA reductase activity reduces 3-ketoacyl-CoA to 3-hydroxyacyl-CoA in each elongation cycle. This enzyme contributes to VLCFA production of varying chain lengths, crucial as precursors for membrane lipids and lipid mediators. Additionally, HSD17B12 may catalyze estrone (E1) conversion to estradiol (E2), suggesting a role in estrogen biosynthesis.

Database Links
Protein Families
Short-chain dehydrogenases/reductases (SDR) family, 17-beta-HSD 3 subfamily
Subcellular Location
Endoplasmic reticulum membrane; Multi-pass membrane protein.

Q&A

What is the primary function of hsd17b12 in Xenopus tropicalis?

Xenopus tropicalis hsd17b12 serves dual biochemical functions. Primarily, it catalyzes the second of the four reactions in the long-chain fatty acids elongation cycle as an endoplasmic reticulum-bound enzyme. This process enables the addition of two carbon atoms to long-chain fatty acids . Additionally, as a member of the hydroxysteroid 17-beta dehydrogenase family, it participates in steroid metabolism by catalyzing the conversion between 17-keto and 17-hydroxysteroids, though its role in fatty acid metabolism appears to be its predominant function in most tissues .

How conserved is hsd17b12 across vertebrate species?

The hsd17b12 gene shows remarkable evolutionary conservation across vertebrate species, suggesting its fundamental importance in core metabolic processes. Comparative genomic analyses have identified hsd17b12 orthologs in humans, mice, chicken, Xenopus tropicalis, coelacanth, spotted gar, zebrafish, fugu, tilapia, medaka, stickleback, and common carp . The gene exhibits universal expression patterns in both human and mouse tissues . This high degree of conservation likely reflects its essential role in fatty acid elongation, as evidenced by the embryonic lethality observed in global Hsd17b12 knockout mice .

What expression patterns does hsd17b12 exhibit during development?

While specific developmental expression data for Xenopus tropicalis hsd17b12 is limited in the provided search results, comparative data from other vertebrates provides insight. In fish models like the orange-spotted grouper, the expression of hsd17b12 homologs (hsd17b12a and hsd17b12b) changes significantly during gonadal development and sex reversal, with downregulation observed during the female-to-male transition . This suggests a potential role in reproductive development. In mice, the enzyme's universal expression pattern and the embryonic lethality of Hsd17b12 knockout indicates essential functions throughout development, particularly in early embryogenesis .

What are the main substrates for hsd17b12 enzymatic activity?

Hsd17b12 demonstrates substrate versatility across two metabolic domains:

  • Fatty acid metabolism: The enzyme primarily functions in the elongation of very long chain fatty acids (VLCFAs), with particular importance in synthesizing arachidonic acid . It catalyzes the reduction of 3-ketoacyl-CoA to 3-hydroxyacyl-CoA in the second step of the fatty acid elongation cycle.

  • Steroid metabolism: As a member of the hydroxysteroid dehydrogenase family, hsd17b12 can catalyze the interconversion of estrone to estradiol, though with lower efficiency than its paralogs specialized in steroid metabolism .

This dual substrate capability explains why hsd17b12 impacts both lipid homeostasis and potentially reproductive development.

How does hsd17b12 deficiency affect metabolic homeostasis?

Global deletion of Hsd17b12 in adult mice produces profound metabolic consequences, demonstrating the enzyme's critical role beyond embryonic development. Experimental evidence from conditional knockout models shows:

  • 20% reduction in body weight

  • Dramatic decrease in both white and brown adipose tissue

  • 44% reduction in food intake

  • 65% decrease in water consumption

  • Preservation of hypothalamic feeding behavior regulation

  • No significant changes in motor activity

These findings suggest that hsd17b12 deficiency disrupts basic metabolic processes, likely through impaired fatty acid elongation and subsequent disruption of lipid-dependent signaling pathways. The preservation of hypothalamic function and motor activity indicates that the metabolic phenotype is not secondary to neurological deficits .

What structural features characterize hsd17b12 and related enzymes?

While the specific crystal structure of Xenopus tropicalis hsd17b12 is not detailed in the search results, structural insights from human 17β-hydroxysteroid dehydrogenase provide valuable comparative information. The human enzyme forms a complex with estradiol and NADP+, with the following key features:

  • Substrate binding involves both hydrogen bonds and hydrophobic interactions

  • Three critical hydrogen bonds form between the substrate and enzyme side chains (Ser142, Tyr155, and His221)

  • The nicotinamide ring of NADP+ positions close to the steroid substrate

  • A triangular hydrogen-bond network between Tyr155, Ser142, and O17 from estradiol facilitates catalysis

These structural insights from related enzymes provide a framework for understanding potential mechanisms of hsd17b12, though species-specific differences should be anticipated.

How do post-translational modifications regulate hsd17b12 activity?

Post-translational modifications likely play important roles in regulating hsd17b12 activity, though specific data for Xenopus tropicalis hsd17b12 is limited. Research methodologies to investigate this include:

  • Phosphorylation analysis: Use mass spectrometry to identify phosphorylation sites and phosphorylation-specific antibodies to correlate modification status with activity levels.

  • Site-directed mutagenesis: Create recombinant variants with mutations at predicted modification sites to assess functional impacts.

  • Inhibitor studies: Use specific inhibitors of modification-related enzymes (kinases, phosphatases, etc.) to determine their effects on hsd17b12 activity.

  • Proteomic analysis: Identify interaction partners that may mediate post-translational modifications under different physiological conditions.

These approaches can reveal how hsd17b12 activity is fine-tuned through non-genomic regulatory mechanisms.

What expression systems yield optimal recombinant Xenopus tropicalis hsd17b12?

For successful expression of functional recombinant Xenopus tropicalis hsd17b12, consider the following expression systems and their advantages:

Expression SystemAdvantagesLimitationsRecommended Applications
E. coliHigh yield, rapid growth, economicalMay lack proper folding for membrane proteins, limited post-translational modificationsInitial structural studies, antibody production
Insect cells (Baculovirus)Eukaryotic folding machinery, moderate post-translational modificationsMore complex than bacterial systems, moderate yieldEnzymatic activity studies, protein-protein interaction assays
Mammalian cellsMost authentic post-translational modifications, proper membrane protein foldingLower yield, expensive, time-consumingFunctional studies requiring native-like enzyme behavior
Xenopus oocytesSpecies-matched cellular environmentIndividual injection required, low throughputElectrophysiological studies, trafficking analysis

When expressing hsd17b12, pay particular attention to its endoplasmic reticulum localization . Including an ER retention signal and using a eukaryotic expression system with intact ER machinery is crucial for obtaining properly localized, functional enzyme.

How can enzymatic activity of recombinant hsd17b12 be measured in vitro?

Multiple complementary approaches can be used to assess hsd17b12 enzymatic activity:

  • Spectrophotometric NADPH oxidation assay:

    • Monitors NADPH consumption at 340 nm during the reduction reaction

    • Provides real-time kinetic data

    • Calculate enzyme activity using NADPH extinction coefficient (ε = 6220 M⁻¹cm⁻¹)

  • Radiolabeled substrate assay:

    • Uses ³H-labeled substrates (fatty acyl-CoAs or steroids)

    • Provides high sensitivity for detecting low activity levels

    • Requires scintillation counting equipment and proper radioactive material handling

  • LC-MS/MS analysis:

    • Directly quantifies substrate and product

    • Distinguishes between different metabolites

    • Offers highest specificity but requires specialized equipment

Each assay should include positive controls (commercially available related enzymes) and negative controls (heat-inactivated enzyme, substrate-free reactions) to validate results.

What strategies enable structural characterization of hsd17b12?

Structural characterization of Xenopus tropicalis hsd17b12 can be approached through:

  • X-ray crystallography:

    • Generate highly purified (>95%) recombinant protein

    • Screen multiple crystallization conditions

    • Co-crystallize with substrates, products, or cofactors to capture different conformational states

    • Optimize based on techniques used for related enzymes like human 17β-HSD1

  • Cryo-electron microscopy:

    • Particularly useful if crystallization proves challenging

    • May better preserve the native conformation, especially for membrane-associated proteins

    • Requires less protein than crystallography

  • Homology modeling:

    • Leverage existing structures from related enzymes (like 1FDS )

    • Validate models through site-directed mutagenesis of predicted catalytic residues

    • Use molecular dynamics simulations to predict protein flexibility

  • Hydrogen-deuterium exchange mass spectrometry:

    • Provides insights into protein dynamics and ligand interactions

    • Useful for mapping conformational changes upon substrate binding

These approaches can reveal the structural basis of substrate specificity and catalytic mechanism.

How can low enzymatic activity of recombinant hsd17b12 be addressed?

When faced with low activity of recombinant Xenopus tropicalis hsd17b12, consider these systematic troubleshooting strategies:

  • Expression system optimization:

    • Switch to eukaryotic expression systems that better support proper folding

    • Include molecular chaperones as co-expression partners

    • Optimize codon usage for the expression host

  • Enzyme preparation improvements:

    • Minimize freeze-thaw cycles and maintain cold chain

    • Add stabilizing agents (glycerol, reducing agents, specific metal ions)

    • Use detergents appropriate for membrane-associated proteins

  • Cofactor considerations:

    • Ensure sufficient NADPH/NADP+ is present in assays

    • Test different cofactor concentrations

    • Verify cofactor quality and stability

  • Assay condition optimization:

    • Systematically vary pH, temperature, ionic strength

    • Include BSA or other stabilizing proteins

    • Test alternative buffer systems

  • Substrate selection:

    • Verify substrate purity and solubility

    • Try different substrate chain lengths if testing fatty acid elongation activity

    • Consider species-specific substrate preferences

Tracking activity improvements through a systematic optimization matrix will efficiently identify critical parameters affecting enzymatic performance.

How can the dual metabolic functions of hsd17b12 be experimentally distinguished?

Distinguishing between the fatty acid elongation and steroid metabolism functions of hsd17b12 requires carefully designed experimental approaches:

  • Selective substrate assays:

    • Test activity using purified fatty acyl-CoA substrates versus steroid substrates

    • Compare relative kinetic parameters (Km, Vmax, kcat) for each substrate class

    • Use competitive inhibition studies to determine preferential binding

  • Site-directed mutagenesis:

    • Target residues predicted to differentially affect one function versus another

    • Create and characterize function-selective mutants

    • Use homology models based on related enzymes to guide mutation design

  • Domain swapping experiments:

    • Exchange domains with related enzymes having more specialized functions

    • Assess how chimeric proteins partition activity between pathways

    • Map substrate selectivity determinants

  • Cell-based functional assays:

    • Introduce wild-type or mutant hsd17b12 into knockout cellular models

    • Measure rescue of fatty acid profiles versus steroid metabolism

    • Use pathway-specific inhibitors to isolate functions

  • In vivo models:

    • Develop tissue-specific or conditional knockouts to assess pathway-specific outcomes

    • Compare phenotypes to those of pathway-specific knockout models

    • Use metabolomic profiling to identify the most affected pathways

These approaches can reveal which function predominates under specific physiological conditions and how the enzyme balances its dual roles.

How should researchers interpret contradictory findings about hsd17b12 function?

When facing contradictory findings regarding hsd17b12 function, follow this systematic approach to resolution:

  • Species-specific differences assessment:

    • Compare experimental conditions across studies reporting contradictory results

    • Consider evolutionary divergence between Xenopus hsd17b12 and orthologs in other species

    • Note that while the gene is widely conserved, subtle functional differences may exist between species

  • Context-dependent function analysis:

    • Evaluate tissue-specific expression patterns and their correlation with observed functions

    • Consider developmental stage-specific roles (embryonic versus adult functions)

    • Examine sex-specific differences in expression and function

  • Methodological comparison:

    • Assess differences in recombinant protein preparation methods

    • Compare in vitro versus in vivo experimental approaches

    • Evaluate differences in substrate concentrations and assay conditions

  • Dual function reconciliation:

    • Consider that apparent contradictions may reflect the enzyme's dual role in fatty acid elongation and steroid metabolism

    • Determine relative importance of each function in different contexts

    • Examine potential crosstalk between lipid and steroid metabolism pathways

  • Data integration approaches:

    • Use multi-omics integration (transcriptomics, proteomics, metabolomics)

    • Develop computational models accounting for multiple functions

    • Design experiments specifically targeting contradictory findings

For example, findings showing embryonic lethality in global knockout mice versus specific metabolic phenotypes in conditional knockouts emphasize the context-dependent nature of hsd17b12 function rather than representing true contradictions.

What kinetic parameters best characterize hsd17b12 enzymatic function?

Comprehensive enzymatic characterization of Xenopus tropicalis hsd17b12 should include determination of the following kinetic parameters:

ParameterDefinitionExperimental ApproachSignificance
KmSubstrate concentration at half-maximal velocityVary substrate concentration, plot Michaelis-Menten curvesIndicates substrate affinity
VmaxMaximum reaction velocitySaturating substrate concentrationsReflects maximum catalytic capacity
kcatTurnover number (catalytic rate constant)Calculate from Vmax and enzyme concentrationMeasures catalytic efficiency per enzyme molecule
kcat/KmSpecificity constantCalculate from determined kcat and KmAllows comparison of efficiency across substrates
KiInhibition constantVary inhibitor concentrationCharacterizes inhibitor potency
pH optimumpH value of maximum activityActivity assays across pH rangeIndicates physiological conditions for function
Temperature optimumTemperature of maximum stability/activityActivity assays across temperature rangeImportant for experimental design

When analyzing these parameters for hsd17b12, particular attention should be paid to:

  • Comparing parameters between fatty acid and steroid substrates

  • Assessing cofactor (NADPH) binding and utilization

  • Determining the rate-limiting step in multi-step reactions

  • Evaluating product inhibition effects

These kinetic analyses provide a quantitative framework for understanding hsd17b12 function and for rational design of inhibitors or activity modulators.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.